بروتوكول علاج كورونا حتي الان

سلام قولا من رب رحيم
خير من سلامي
واتقوا فتنة لا تصيبن الذين ظلموا منكم خاصة واعلموا أن الله شديد العقاب
البروتوكول المتبع في مجابهه covid (كورونا) حتي الان
اولا
دواء اسمه plaquenil الماده الفعاله Hydroxychloroquine يستخدم اساسا في علاج الملاريا وبعض الامراض المناعيه...
ثانيا
دواء ZITHROMAX الماده الفعالهAzithromycin اثبتت بعض التجارب السريره ان له augmentation تاثير محفز لHydroxychloroquine

ثالثا
zinc supplement الزنك له دور في زياده المناعه عشان بيقلل انقسام الفيروس داخل الخلايا بس مشكلته انه مبيدخلش الخليه بكم كبير والكلام يطول عن mechanism عمله

المهم الادويه دي اثبتت فعاليتها في تثبيط الفيروس ومساعده المناعه علي الرغم ان منظمه الصحه العالميه لم تعتمدها حتي الان بس ده البروتوكول المعتمد حتي الان من الصين وفرنسا ...... الخ مع اختلاف الطريقه فقط
الادويه متاحه ورخيصه بس استخدامها من غير متابعه ممكن يدخل في سميه من الدواء او اعراض جانبيه ف حالات فرط الاستخدام او مع حالات مرضيه اخري
تب ممكن ناخد زنك !
اها ممكن فيه حبوب فيتامينات فيها زنك وvit c وسهله ورخيصه
بس حبايه يوميا وبلاش نبحبحها...


ده تقرير عن الكلام اللي فوق
A renowned research professor in France has reported successful results from a new treatment for Covid-19, with early tests suggesting it can stop the virus from being contagious in just six days.

Professor Didier Raoult from infection hospital l'Institut Hospitalo-Universitaire (IHU) Méditerranée Infection in Marseille (Bouches-du-Rhône, Provence-Alpes-Côte d'Azur), published a video explaining the trials on Monday March 16.

Professor Raoult is an infectious diseases specialist and head of the IHU Méditerranée Infection, who has been tasked by - and consulted by - the French government to research possible treatments of Covid-19.

He said that the first Covid-19 patients he had treated with the drug chloroquine had seen a rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious.

Chloroquine - which is normally used mainly to prevent and treat malaria - was administered via the named drug, Plaquenil.

The treatment was offered to 24 patients, who were among the first to become infected in the south east of France, and who had voluntarily admitted themselves to hospital for the process.

Patients were given 600mcg per day for 10 days. They were closely monitored, as the drug can interact with other medication, and cause severe side effects in some cases.

Professor Raoult said: “We included everyone who was in agreement [to be treated], which was almost everyone. Two towns in the protocol, Nice and Avignon, gave us [infected] patients who had not yet received treatment.

“We were able to ascertain that patients who had not received Plaquenil (the drug containing hydroxychloroquine) were still contagious after six days, but of those that had received Plaquenil, after six days, only 25% were still contagious.”

Chloroquine phosphate and hydroxychloroquine have previously been used to treat coronavirus patients in China, in ongoing Covid-19 clinical trials.

Kaletra, a US-based antiviral drug normally used to treat HIV, is another medicine that is being tested in the fight against Covid-19.